BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7931205)

  • 21. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
    Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and behavioral treatments of cocaine dependence: controlled studies.
    O'Brien CP; Childress AR; Arndt IO; McLellan AT; Woody GE; Maany I
    J Clin Psychiatry; 1988 Feb; 49 Suppl():17-22. PubMed ID: 3276670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of amlodipine for cocaine dependence: a negative report.
    Malcolm R; LaRowe S; Cochran K; Moak D; Herron J; Brady K; Hedden S; Woolson R; Halushka P
    J Subst Abuse Treat; 2005 Mar; 28(2):197-204. PubMed ID: 15780550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients.
    Campbell J; Nickel EJ; Penick EC; Wallace D; Gabrielli WF; Rowe C; Liskow B; Powell BJ; Thomas HM
    Am J Addict; 2003; 12(2):122-36. PubMed ID: 12746087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.
    Weddington WW; Brown BS; Haertzen CA; Hess JM; Mahaffey JR; Kolar AF; Jaffe JH
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):137-52. PubMed ID: 1862788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care.
    Stahler GJ; Mennis J; Cotlar R; Baron DA
    Am J Psychiatry; 2009 Nov; 166(11):1258-68. PubMed ID: 19797433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic treatments of cocaine abuse.
    Gawin F; Kleber H
    Psychiatr Clin North Am; 1986 Sep; 9(3):573-83. PubMed ID: 3534819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
    Arndt IO; McLellan AT; Dorozynsky L; Woody GE; O'Brien CP
    J Nerv Ment Dis; 1994 Mar; 182(3):151-6. PubMed ID: 8113775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief coping skills treatment for cocaine abuse: substance use outcomes at three months.
    Monti PM; Rohsenow DJ; Michalec E; Martin RA; Abrams DB
    Addiction; 1997 Dec; 92(12):1717-28. PubMed ID: 9581004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.
    Campbell JL; Thomas HM; Gabrielli W; Liskow BI; Powell BJ
    J Addict Dis; 1994; 13(4):191-9. PubMed ID: 7734469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desipramine treatment of cocaine dependence in methadone-maintained patients.
    Arndt IO; Dorozynsky L; Woody GE; McLellan AT; O'Brien CP
    Arch Gen Psychiatry; 1992 Nov; 49(11):888-93. PubMed ID: 1444727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
    Kosten TR; Morgan CM; Falcione J; Schottenfeld RS
    Arch Gen Psychiatry; 1992 Nov; 49(11):894-8. PubMed ID: 1444728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral contingencies improve counseling attendance in an adaptive treatment model.
    Brooner RK; Kidorf MS; King VL; Stoller KB; Peirce JM; Bigelow GE; Kolodner K
    J Subst Abuse Treat; 2004 Oct; 27(3):223-32. PubMed ID: 15501375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.
    Carroll KM; Nich C; Rounsaville BJ
    J Nerv Ment Dis; 1995 Apr; 183(4):251-9. PubMed ID: 7714514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes for cocaine abusers after once-a-week psychosocial therapy.
    Kang SY; Kleinman PH; Woody GE; Millman RB; Todd TC; Kemp J; Lipton DS
    Am J Psychiatry; 1991 May; 148(5):630-5. PubMed ID: 1850208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research on desipramine in the treatment of cocaine abuse: a critique of Levin and Lehman's meta-analysis.
    Delucchi KL
    J Clin Psychopharmacol; 1992 Oct; 12(5):367-70. PubMed ID: 1479061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.